NCT00083434

Brief Summary

The purpose of this study is to examine the effectiveness of epoetin alfa in treating anemia in patients who have cancer or who no longer have any signs of the cancer, but remain anemic as a result of their treatment.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Feb 2004

Shorter than P25 for phase_3

Geographic Reach
1 country

6 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2004

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 24, 2004

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 26, 2004

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2004

Completed
Last Updated

April 27, 2011

Status Verified

April 1, 2011

First QC Date

May 24, 2004

Last Update Submit

April 25, 2011

Conditions

Keywords

AnemiaCancer

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • Body weight \>/= 99lbs
  • ECOG 0-2
  • Anemia results from cancer, chemotherapy, radiotherapy or an association with hormonal therapy or immunotherapy
  • Screening hemoglobin level of \</= 11.0 g/dL for men or \</= 10.0 for women

You may not qualify if:

  • History of or concurrent second malignancy
  • Evidence of primary or metastatic malignancy involving the Central Nervous System

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Advanced Urology Medical Center

Anaheim, California, 92801, United States

Location

Shapiro, Stafford & Yee

Arcadia, California, 91007, United States

Location

California Cancer Center

Fresno, California, 93720, United States

Location

Tukoi Research

North Miami, Florida, 33161, United States

Location

Hanover Medical Specialists, PA

Wilmington, North Carolina, 28401, United States

Location

Madigan Army Medical Center Urology Services

Tacoma, Washington, 98431-5000, United States

Location

Related Links

MeSH Terms

Conditions

AnemiaNeoplasms

Interventions

Epoetin Alfa

Condition Hierarchy (Ancestors)

Hematologic DiseasesHemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

ErythropoietinColony-Stimulating FactorsGlycoproteinsGlycoconjugatesCarbohydratesHematopoietic Cell Growth FactorsCytokinesIntercellular Signaling Peptides and ProteinsPeptidesAmino Acids, Peptides, and ProteinsProteinsBiological Factors

Study Design

Study Type
interventional
Phase
phase 3
Purpose
TREATMENT
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

May 24, 2004

First Posted

May 26, 2004

Study Start

February 1, 2004

Study Completion

October 1, 2004

Last Updated

April 27, 2011

Record last verified: 2011-04

Locations